Open Beta
MetriLume

US marketsOFIX

SEC-sourced researchBeta

OFIX

Orthofix Medical Inc.

Company comparison ↗

Data passport

CIK
0000884624
Exchange
Nasdaq
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Oct 5, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 746,641,000.0000 USD; December 2024: 799,491,000.0000 USD; December 2025: 822,312,000.0000 USD822.3M USD0 USD0December 2023December 2024December 2025
OFIX · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023746,641,000.0000Feb 24, 2026
December 2024799,491,000.0000Feb 24, 2026
December 2025822,312,000.0000Feb 24, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025822,312,000.0000-92,192,000.000033,347,000.0000850,647,000.0000400,610,000.0000Feb 24, 2026
December 2024799,491,000.0000-125,997,000.000025,790,000.0000893,294,000.0000390,170,000.0000Feb 24, 2026
December 2023746,641,000.0000-151,395,000.0000-45,753,000.0000——Feb 24, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$822.31MDecember 2025Feb 24, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$799.49MDecember 2024Feb 24, 202610-K
Net incomeNetIncomeLoss-$92.19MDecember 2025Feb 24, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$33.35MDecember 2025Feb 24, 202610-K
Total assetsAssets$850.65MDecember 2025Feb 24, 202610-K
Total liabilitiesLiabilities$400.61MDecember 2025Feb 24, 202610-K

New filings

Explore methodology ↗